ProSomnus Sleep Technologies

What ProSomnus Sleep Technologies does

ProSomnus Sleep Technologies designs and manufactures precision-engineered intraoral medical devices for the treatment of obstructive sleep apnea (OSA), serving dental sleep medicine providers, sleep physicians, and OSA patients globally. The company's core technology is a 'Smart Sleep Medicine' platform that combines custom-fabricated oral appliances with embedded physiologic monitoring — most notably the FDA-cleared RPMO2 OSA Device, which is the first theragnostic device in sleep medicine to integrate oral appliance therapy with multi-night SpO2 and pulse rate measurement via an intraoral buccal mucosal oximeter, transmitting data through the Oxymetrx smartphone app and a HIPAA-compliant Provider Portal. Supporting the platform are the EVO family of devices (EVO, EVO Select, EVO Guided, EVO [PH]), the HWO2 buccal mucosal wellness oximeter, and the Morning Occlusal Guide (MOG), all protected by an IP portfolio of 11+ granted US patents, an EU patent validated in France/Germany/UK, and a pipeline of pending applications covering device architecture, iterative titration, and automated manufacturing.

The company operates a B2B2C go-to-market: ProSomnus sells direct to dentists and sleep medicine providers through a sales-led motion, supported by a provider portal, starter kits, CE courses, and clinical education, while end-patients are reached via provider prescription. Devices are reimbursed through commercial insurance, Medicare, TRICARE, and government-sponsored plans representing more than 200 million covered lives, with the company stating a 33% lower lifetime net device cost versus CPAP. Headquartered in Pleasanton, California, with regional offices in Munich and Oberentfelden (Switzerland), ProSomnus claims a network of thousands of providers globally and more than 100,000 cumulative users, generating revenue primarily from hardware sales supplemented by recurring remote patient monitoring services and warranty/replacement contracts.

The corporate history includes a December 2022 SPAC merger with Lakeshore Acquisition I Corp. (Nasdaq: OSA, ~$168M valuation), a voluntary Chapter 11 filing in August 2024 that reduced debt by approximately 60% and took the company private with $20M in new financing, and a subsequent $38M strategic investment from Catalio Capital Management in February 2026 to fund global expansion and next-generation RPM/diagnostic development. Ownership remains anchored by healthcare-focused private equity firm HealthpointCapital LLC, with other institutional backers including Spring Mountain Capital, Littlejohn & Co., and Masters Special Situations.

Name

ProSomnus Sleep Technologies

Legal name

ProSomnus Sleep Technologies, Inc.

Website

https://prosomnus.com

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

101–250 employees

Short description

ProSomnus Sleep Technologies designs and manufactures precision-engineered intraoral medical devices and the FDA-cleared RPMO2 theragnostic platform for obstructive sleep apnea treatment, sold direct to dental sleep medicine providers and reimbursed by commercial insurance, Medicare, and TRICARE across the US, Germany, and Switzerland.

Ownership category

akta.pro rank

Product category

Sleep Apnea Medical Devices

NAICS

Surgical Appliance and Supplies Manufacturing (339113), Surgical and Medical Instrument Manufacturing (339112), Dental Laboratories (339116), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Dental Equipment & Supplies (3843), Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Sleep & Airway Orthodontics (OSA Appliances/Expansion) (HLABABAI)

akta.pro secondary industries

Sleep Diagnostics & Monitoring (PSG/Home Sleep Testing, Actigraphy) (HLAHAGAB), Pulmonology & Sleep Medicine Telemedicine Platforms (HLALAGAF)

Keywords

• Oral appliance therapy
• Sleep apnea devices
• Intraoral medical devices
• Dental sleep medicine
• Remote patient monitoring

Headquarters

HQ city

Pleasanton

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Personnel, Technology or R&D, Marketing or Sales, Supply Chain

Revenue model

1. Medical Device Sales: Sale of FDA-cleared intraoral medical devices for obstructive sleep apnea treatment. Devices are covered by commercial insurance, Medicare, and TRICARE, representing over 200 million covered lives globally. Revenue is generated through provider orders via portal.
2. Remote Patient Monitoring Services: Connected care services through the RPMO2 platform enabling multi-night physiologic monitoring, with data transmitted to providers via smartphone application and provider portal.
3. Warranty and Replacement Services: Device warranty policies and replacement services for oral appliances.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels6 records

Core offering

ProSomnus Sleep Technologies designs, manufactures, and sells FDA-cleared precision intraoral medical devices for the treatment of obstructive sleep apnea (OSA) and snoring. The company sells directly to dentists, dental sleep medicine providers, and sleep physicians through its provider portal, with devices reimbursed by commercial insurance, Medicare, and TRICARE. The portfolio includes the EVO family of oral appliances (EVO, EVO Select, EVO Guided, EVO PH) and the RPMO2 OSA Device, which is the first FDA-cleared theragnostic device combining oral appliance therapy with multi-night physiologic monitoring.

Product overview

ProSomnus Sleep Technologies offers a portfolio of precision oral appliance therapy devices for obstructive sleep apnea (OSA) treatment, led by the EVO product line (EVO, EVO Select, EVO Guided, EVO PH) and the connected RPMO2 theragnostic platform. The portfolio also includes the HWO2 wellness oximeter and Morning Occlusal Guide. The EVO devices are custom-fabricated precision oral appliances FDA-cleared for OSA treatment, while RPMO2 integrates physiologic monitoring (SpO2, pulse rate) with therapy via embedded oximetry and companion app/portal. Supporting software includes the Oxymetrx patient app and provider portal for data access.

Differentiator

Problem solved

Functional benefit

Brands

• EVO: Precision oral appliance therapy device for obstructive sleep apnea treatment
• EVO Guided
• EVO Select
• EVO PH
• RPM02 OSA Device
• MOG (Morning Occlusal Guide)
• Smart Sleep Medicine
• HWO2

Products and services

• ProSomnus EVO Sleep and Snore Device FDA-cleared precision oral appliance providing patient-preferred OSA therapy as a non-CPAP alternative for treating obstructive sleep apnea and snoring, prescribed and fitted by dentists and dental sleep medicine providers.
• ProSomnus EVO Select Sleep and Snore Device Precision oral appliance engineered for performance, biocompatibility, and maximum patient comfort for the treatment of obstructive sleep apnea and snoring; custom-fabricated and FDA-cleared.
• ProSomnus EVO Guided Sleep and Snore Device First oral device bioengineered to dilate both the velopharynx and oropharynx, featuring a 95-degree guided prescription mechanism and anatomical splint design providing up to 14 times more tongue space, for obstructive sleep apnea and snoring treatment.
• ProSomnus EVO [PH] Sleep and Snore Device
• ProSomnus RPMO2 OSA Device First FDA-cleared theragnostic device for sleep medicine combining precision oral appliance therapy with multi-night physiologic monitoring in a single device; measures oxygen saturation (SpO2) and pulse rate via intraoral buccal mucosal oximeter with data transmitted to providers through the Oxymetrx smartphone app and provider portal.
• ProSomnus HWO2 Device Buccal mucosal wellness oximeter enabling patients to monitor nightly health and wellness during sleep, specifically blood oxygen saturation, pulse rate, and overall use time from smartphones.

Quantifiable outcome

• 96% patient satisfaction rate vs CPAP and traditional solutions
• +6 more outcomes

Named customers8 records

Segments4 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

Feature5 records

Partnerships

One partnership is on record.

• MonitAircoreTechnology or Integration · 15 June 2026Collaboration to integrate ProSomnus's FDA-cleared RPMO2 OSA Device with MonitAir's remote patient monitoring platform for managing obstructive sleep apnea patients. The integration enables continuous, multi-night physiologic data monitoring and supports care coordination across clinical workflows through MonitAir's HIPAA-compliant platform that aggregates remote physiologic monitoring, remote therapeutic monitoring, and chronic care management capabilities.

Scale indicators10 records

Recent moves8 records

Expansion highlights6 records

Direct peers

• SomnoMed: Global leader in mandibular advancement devices for OSA, offering competing oral appliances (SomnoDent) sold through dentists and sleep physicians. Closest direct competitor to ProSomnus's EVO line in the OAT category with similar provider channel and insurance reimbursement model.
• Vivos Therapeutics: Developer of the Vivos System, a dental appliance-based treatment for mild-to-moderate OSA targeting dental sleep medicine providers. Competes directly with ProSomnus for the same dental sleep channel and OSA patient population.
• Panthera Dental: Manufacturer of CAD/CAM-milled mandibular advancement devices (Panthera D-SAD) for sleep apnea. Direct competitor in the precision-engineered OAT segment with comparable dentist-channel distribution and clinical positioning.
• Airway Management: Developer of the TAP (Thornton Adjustable Positioner) oral appliances for OSA and snoring. Established direct competitor in the dental sleep medicine market targeting similar patient and provider segments as ProSomnus.

Broad incumbents

• ResMed: Dominant global player in sleep-disordered breathing with CPAP/APAP devices and growing OAT portfolio (acquired Whole You). Represents the largest incumbent competitor and a broad market leader across OSA treatment modalities.
• Philips Respironics: Major incumbent offering CPAP devices and competing OSA solutions. Despite ongoing recall-related headwinds, remains a significant force in sleep apnea treatment and competes for payer attention and provider mindshare.
• Inspire Medical Systems: Public medtech company commercializing hypoglossal nerve stimulation (Inspire UAS) as a surgical alternative for moderate-to-severe OSA. Competes for the same severe-OSA patient pool and sleep physician referrals as ProSomnus.

Regional players

• Oventus Medical: Australia-based developer of O2Vent oral appliances for OSA, focused primarily on the APAC region. Comparable precision-engineered OAT offering with differentiated airway channel design, though serving a different geographic market than ProSomnus's US/EU core.

Others

• Itamar Medical (ZOLL/ResMed): Sleep diagnostics platform (WatchPAT) for home sleep testing, now part of ZOLL/ResMed. Adjacent ecosystem player providing OSA diagnosis that drives downstream OAT/CPAP prescribing, complementary to ProSomnus's therapy positioning.
• Natus Medical: Provider of neurodiagnostic and sleep diagnostic equipment including PSG systems used in sleep labs. Enabling player in the OSA value chain that complements ProSomnus's therapy devices with the diagnostic infrastructure that generates referrals.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks7 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/channel/UCwjmcOjlo1fj0iT4CoW2S3Q
• Facebookfacebook.com/ProSomnusSleepTechnologies
• LinkedInlinkedin.com/company/prosomnus-sleep-technologies
• Instagraminstagram.com/prosomnussleeptechnologies
• Xx.com/prosomnus

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles17 records

Subsidiaries2 records

Funding overview

Funding rounds6 records

Investors5 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ProSomnus Sleep Technologies